Will new pharma startups bring down drug prices in 2026? Learn how companies like Valera Health aim to reduce costs for consumers.
Aaron Frost
·
72% of opinions are formed by packaging. Learn why startup brand refreshes boost customer acquisition by 10-20% and ROI by 3x.
·
Construction tech VC funding dropped 30% in 2025. Learn why and how startups must adapt funding strategies for a cautious market.
·
Iambic's confidential S-1 filing offers insights for startups. See how this AI chip company prepares for a 2026 IPO and what it means for you.
·
2026 drug pricing debates threaten biotech startups. Learn how small firms can advocate for innovation and survive amidst calls for lower costs.
·
·
8 min read
Big Pharma spent $300M+ lobbying in 2025. See how this distorts policy, hurting biotech startups and innovation. What to watch next.
·
·
7 min read
How can pharma policy foster innovation? See how new rules aim to cut approval times by 15% for biotech startups by 2026.
·
·
8 min read
Struggling with B2B sales? See how AI cut Apex Solutions' sales cycle by 25%, boosting efficiency and forecasting accuracy by 15-20%.
·
·
8 min read
Iambic's new AI platform aims to accelerate drug development. Learn how it uses multimodal data to deliver candidates in 12-18 months.
·
·
7 min read
75% of B2B firms use APIs strategically. See how Goldstar uses API development to gain market share, drive revenue, and boost efficiency.
·
·
6 min read
